12:00 AM
Oct 14, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Breast cancer Tumor necrosis factor receptor superfamily member 11a (TNFRSF11A; RANK; CD265); receptor activator of NF-kB ligand (RANKL; TNFSF11) Mouse studies suggest that inhibiting RANKL...

Read the full 286 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >